Microbiology
-
Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo
This article has 18 authors:Reviewed by ScreenIT
-
Rapid development of SARS-CoV-2 receptor binding domain-conjugated nanoparticle vaccine candidate
This article has 19 authors:Reviewed by ScreenIT
-
The lethal triad: SARS-CoV-2 Spike, ACE2 and TMPRSS2. Mutations in host and pathogen may affect the course of pandemic
This article has 4 authors:Reviewed by ScreenIT
-
A novel cell culture system modeling the SARS-CoV-2 life cycle
This article has 13 authors:Reviewed by ScreenIT
-
Simple rapid in vitro screening method for SARS-CoV-2 anti-virals that identifies potential cytomorbidity-associated false positives
This article has 4 authors:Reviewed by ScreenIT
-
An Engineered Receptor-Binding Domain Improves the Immunogenicity of Multivalent SARS-CoV-2 Vaccines
This article has 15 authors:Reviewed by ScreenIT
-
Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event
This article has 6 authors:Reviewed by ScreenIT
-
Structural characterization of nonstructural protein 1 from SARS-CoV-2
This article has 3 authors:Reviewed by ScreenIT
-
Discovery of five HIV nucleoside analog reverse-transcriptase inhibitors (NRTIs) as potent inhibitors against the RNA-dependent RNA polymerase (RdRp) of SARS-CoV and 2019-nCoV
This article has 1 author:Reviewed by ScreenIT
-
Respiratory disease in cats associated with human-to-cat transmission of SARS-CoV-2 in the UK
This article has 20 authors:Reviewed by ScreenIT